Marcopolo S.A. (BVMF:POMO3)

Verve Therapeutics Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,249	7,625	6,142	2,514	2,678	2,645
Market Cap Growth	26.93%	24.14%	144.28%	-6.11%	1.26%	-37.38%
Enterprise Value	10,738	8,860	7,293	4,034	3,958	3,979
Last Close Price	7.01	5.32	4.02	1.58	1.55	1.63
PE Ratio	7.70	6.35	7.53	5.60	7.31	25.47
PS Ratio	1.03	0.89	0.92	0.46	0.77	0.74
PB Ratio	2.19	1.87	1.71	0.79	0.91	1.01
P/TBV Ratio	2.39	2.05	1.86	0.89	1.05	1.20
P/FCF Ratio	10.72	8.34	6.67	-	30.37	58.34
P/OCF Ratio	7.99	6.13	5.79	55.42	14.23	15.05
EV/Sales Ratio	1.20	1.03	1.09	0.75	1.13	1.11
EV/EBITDA Ratio	6.82	5.76	7.25	9.44	12.45	13.18
EV/EBIT Ratio	7.58	6.33	8.23	13.13	18.64	19.33
EV/FCF Ratio	12.44	9.69	7.92	-	44.89	87.77
Debt / Equity Ratio	0.80	0.82	0.69	0.76	0.81	0.81
Debt / EBITDA Ratio	2.20	2.14	2.42	5.72	7.49	6.96
Debt / FCF Ratio	3.93	3.65	2.70	-	27.01	46.36
Asset Turnover	1.00	0.99	0.87	0.77	0.56	0.65
Inventory Turnover	3.52	3.75	3.48	3.94	3.62	4.60
Quick Ratio	1.18	1.24	1.34	1.17	1.09	1.31
Current Ratio	1.87	1.84	2.02	1.81	1.66	1.85
Return on Equity (ROE)	30.56%	31.87%	23.87%	14.18%	12.88%	3.65%
Return on Assets (ROA)	9.57%	10.06%	7.22%	2.73%	2.12%	2.33%
Return on Capital (ROIC)	12.17%	12.96%	9.45%	3.50%	2.64%	2.90%
Return on Capital Employed (ROCE)	21.40%	22.00%	15.90%	6.00%	4.60%	5.00%
Earnings Yield	12.98%	15.74%	13.29%	17.86%	13.69%	3.93%
FCF Yield	9.33%	12.00%	14.98%	-1.79%	3.29%	1.71%
Dividend Yield	8.11%	15.40%	4.98%	12.34%	-	-
Payout Ratio	50.37%	55.26%	41.13%	19.77%	4.51%	67.37%
Buyback Yield / Dilution	-	0.00%	-0.12%	-0.06%	-0.80%	1.28%
Total Shareholder Return	8.11%	15.40%	4.86%	12.28%	-0.80%	1.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.